A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids

Journal of Lipid Research

Volumn 42, Issue 8, 2001, Pages 1308-1317

  Navab, M ^a   Hama, S Y ^a   Hough, G P ^a   Subbanagounder, G ^a   Reddy, S T ^a   Fogelman, A M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; HPETE; HPODE; LDL; Mildly oxidized LDL

Indexed keywords

DEXTRAN SULFATE; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID; PHOSPHORYLCHOLINE; STEARIC ACID DERIVATIVE;

ARTICLE; ASSAY; CELL FREE SYSTEM; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FAST PROTEIN LIQUID CHROMATOGRAPHY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID OXIDATION; MOUSE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; AORTA; CELL-FREE SYSTEM; CHEMOTAXIS, LEUKOCYTE; CLUSTERIN; COCULTURE TECHNIQUES; CORONARY ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; FEMALE; FLUORESCEINS; FLUORESCENT DYES; GLYCOPROTEINS; HUMANS; LINOLEIC ACIDS; LIPID PEROXIDATION; LIPID PEROXIDES; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MOLECULAR CHAPERONES; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; OXIDATION-REDUCTION; PHOSPHOLIPID ETHERS; SPECTROMETRY, FLUORESCENCE;

EID: 0034891279     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Normal HDL inhibits three steps in the formation of mildly oxidized LDL - Step 1
2. Normal HDL inhibits three steps in the formation of mildly oxidized LDL - Steps 2 and 3
3. Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease
4. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
5. The antiatherogenic role of high-density lipoprotein cholesterol
6. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio
7. Overexpression of apolipoprotein AII in mice converts high density lipoprotein to a pro-inflammatory particle
8. Role of group II secretory phospholipase A2 in atherosclerosis. 2. Potential involvement of biologically active oxidized phospholipids
9. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
10. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures
11. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein-1 synthesis and is abolished by high density lipoprotein
12. Modification of the Recalde method for the isolation of human monocytes
13. The distribution and chemical composition of ultracentrifugally separated lipoproteins of human serum
14. Electrophoretic separation of plasma lipoproteins in agarose gel
15. Cigarette smoking increases endothelial-derived vasorelaxation in the rat carotid artery in a dose-dependent manner
16. A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescein-diacetate
17. A fluorescent based protein assay for use with a microplate reader
18. Protein measurement with the Folin phenol reagent
19. A spectrophotometric microtiter-based assay for detection of hydroperoxy derivatives of linoleic acid
20. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model
21. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density' lipoprotein
22. Paraoxonase prevents accumulation of lipoperoxides in low density lipoprotein
23. Paraoxonase inhibits high-density lipoprotein oxidation and preserves functions. A possible peroxidative role for paraoxonase
24. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions. PON1 esterase and peroxidase-like activities
25. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis
26. The platelet activating factor acetylhydrolase from human plasma prevents oxidative modification of low density, lipoprotein
27. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein
28. Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation
29. Impaired function of lecithin:cholesterol acyltransferase in atherosclerosis-susceptible White Carneau pigeons: Possible effects on metabolism of oxidized phospholipids
30. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: Studies with platelet-activating factor acetylhydrolase-deficient plasma
31. A novel lecithin acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation
32. Metabolism of oxidized phosphatidylcholines formed in oxidized low density lipoprotein by lecithin-cholesterol acyltransferase
33. Physiologic concentrations of homocysteine inhibit the human plasma GSH peroxidase that reduces organic hydroperoxides
34. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
35. Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to the abnormal composition of HDL